Established from a grade II mucous producing and grade III solid rectal adenocarcinoma from a 66 year old Caucasian female. The cells form brush borders and...
GP2d has been established from the same adenocarcinoma as GP5d. This has been confirmed by STR profiling at. The cells were derived from a local recurrence...
Established in 1974 from the second in a series of 3 primary colonic tumours resected from a 65 year old Caucasian female, which was classified as a Duke's B...
Derived from a grade III adenocarcinoma of the colon in a 53 year old female. CEA is produced and electron microscopy reveals the presence of brush borders...
Subclone of parent HT-29 which was established from an adenocarcinoma from a 44 year old Caucasian female. Tumorigenic in nude mice and has ability to grow...
Cells possess Ca antigen as defined by the Ca1 antibody. The Ca antigen has been shown to be absent in non-malignant human cell strains and is considered to...
A subclone of the parent HT29-18 differentiated to specific cell types for studies on cystic fibrosis.
The human colon cancer cell line, HCA-7 Colony 29 expresses Cox-2. An interesting feature of this cell line is that it forms polarised epithelial sheets...
Established from a colon adenocarcinoma of a 58 year-old female patient. The adenocarcinoma was moderately differentiated and determined to be Dukes' stage...
Established from a sigmoid colon adenocarcinoma of a 83 year-old female patient. The adenocarcinoma was well differentiated and determined to be Dukes' stage...
Established from an adenocarcinoma located in the ascending colon of a 68 year-old male patient. The adenocarcinoma was well differentiated and determined to...
Established from a sigmoid colon adenocarcinoma of a 53 year-old female patient. Imperial College Innovations has stated that this cell line is not to be...
The cell line MDST8, also known as T8, has been established from human colorectal tumour explants. It has been applied in gene therapy studies using...
GP5d has been established from the same adenocarcinoma as GP2d. The cells were derived from a local recurrence of Duke's grade B, poorly differentiated...
RKO is a poorly differentiated colon carcinoma cell line developed by Michael Brattain.
This line has never been trypsinized; however, the variant LS 174T (ATCC�CL-188)�has been subcultured by trypsinization.
The STC-1 cell line was derived from the intestinal tumors of RIP1Tag2/Rip2pyST1 double transgenic mice.
Morphologically the cells resemble epithelial cells; however, the cells do not contain keratin and definitive evidence of epithelial origin is lacking.